ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,191, issued on Sept. 2, was assigned to BOEHRINGER INGELHEIM VETMEDICA GMBH (Ingelheim am Rhein, Germany).
"Attenuated IBV with extended cell culture and tissue tropism" was invented by Egbert Siegfried Mundt (Lyons, France), Annika Kraemer-Kuehl (Seesen, Germany), Rosalba De La Mora Quiroz (Guadalajara Jalisco, Mexico), Jose Francisco Robles Gonzalez (County Nueva Oxtotitlan, Mexico) and Thomas Min Stephan (Hannover, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates i.a. to an IBV (infectious bronchitis virus) deposited with the BVR of IZSLER under accession number DPS RE RSCIC 16, any descendant IBV thereof and a...